We focus on providing generics in the therapeutic areas of infectious diseases, cardiology, neurology, gastroenterology and endocrinology.

We manage our network of manufacturing and delivery of affordable, high-quality pharmaceuticals across Africa. Each year, we provide over 100m treatments across 25 markets.

We envisage our company growing to become one of the leading global pharmaceutical manufacturers.

Since 1994, through our businesses, we pursue our core purpose of providing a better quality of life for all in communities across the region by providing better medication for humans and animals (Pharmaceutical and Animal Health).